Whitehawk Therapeutics (WHWK) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to -$287.3 million.
- Whitehawk Therapeutics' Enterprise Value fell 35875.21% to -$287.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$287.3 million, marking a year-over-year decrease of 35875.21%. This contributed to the annual value of -$47.2 million for FY2024, which is 5660.16% up from last year.
- According to the latest figures from Q3 2025, Whitehawk Therapeutics' Enterprise Value is -$287.3 million, which was down 35875.21% from -$209.5 million recorded in Q2 2025.
- Whitehawk Therapeutics' 5-year Enterprise Value high stood at -$36.8 million for Q2 2021, and its period low was -$287.3 million during Q3 2025.
- Over the past 5 years, Whitehawk Therapeutics' median Enterprise Value value was -$129.8 million (recorded in 2022), while the average stood at -$132.1 million.
- Per our database at Business Quant, Whitehawk Therapeutics' Enterprise Value skyrocketed by 5660.16% in 2024 and then plummeted by 35875.21% in 2025.
- Quarter analysis of 5 years shows Whitehawk Therapeutics' Enterprise Value stood at -$149.0 million in 2021, then decreased by 15.82% to -$172.6 million in 2022, then soared by 36.92% to -$108.8 million in 2023, then soared by 56.6% to -$47.2 million in 2024, then plummeted by 508.14% to -$287.3 million in 2025.
- Its Enterprise Value stands at -$287.3 million for Q3 2025, versus -$209.5 million for Q2 2025 and -$231.1 million for Q1 2025.